R92.32

Clinical Causes: Natural variation in breast tissue composition Hormonal influences, such as fluctuations related to menstrual cycles, pregnancy, or menopause Genetic factors affecting breast tissue density Age-related changes in breast tissue structure Lifestyle factors which may influence tissue density, such as body weight and reproductive history

Key Symptoms: Typically, no symptoms are associated with fibroglandular density, as it is an imaging characteristic rather than a clinical condition. In some cases, dense breast tissue may make it more difficult to detect abnormalities on a mammogram, potentially leading to missed diagnoses. Breast discomfort or pain is generally not related to fibroglandular density. Palpable lumps are usually not caused by tissue density but require further investigation if present.

Diagnosis Path: The assessment of fibroglandular density is made through mammography, a widely used imaging technique for breast screening. During a mammogram, radiologists evaluate the tissue composition and classify density using the BI-RADS system. A classification of BI-RADS 2 indicates the tissue is mostly non-dense, with a low likelihood of associated pathology. No additional diagnostic procedures are typically necessary beyond routine screening unless symptoms or other findings prompt further evaluation.

Treatment Protocols: Since fibroglandular density of the breast is a benign tissue characteristic, no specific treatment is required. The focus is on routine breast health management and appropriate screening intervals. If dense tissue complicates imaging, supplementary techniques such as ultrasound or MRI may be considered, but these are not dictated solely by tissue density and depend on individual risk factors.